Posted by ABMN Staff on May 1st, 2024
HCA Healthcare (NYSE:HCA – Get Free Report) had its target price upped by stock analysts at Royal Bank of Canada from $322.00 to $329.00 in a note issued to investors on Monday, Benzinga reports. The firm currently has an “outperform”...
More of this article »